Antioxidants in Patients Treated for Cancer
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
For our patients undergoing cancer treatment, what role do antioxidant substances play? Further, should we encourage or actively discourage these patients from taking them? Dr. Brian Lawenda, assistant professor of radiation oncology at the Indiana University School of Medicine, discusses the rationale for and against the use of antioxidants in patients receiving both chemotherapy and radiation therapy with your host, Dr. Lee Freedman.
Overview
For our patients undergoing cancer treatment, what role do antioxidant substances play? Further, should we encourage or actively discourage these patients from taking them? Dr. Brian Lawenda, assistant professor of radiation oncology at the Indiana University School of Medicine, discusses the rationale for and against the use of antioxidants in patients receiving both chemotherapy and radiation therapy with your host, Dr. Lee Freedman.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Innovations in the Management of Hemolytic Disease of the Fetus and Newborn: The Role of the Neonatal Fc Receptor (FcRn) Pathway
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
I'm Getting the Hang of This! I Have Two Patients: One At 'Indeterminate Risk' and One At 'High Risk' for Clinically Significant Fibrosis
Beyond Longevity: Discussing TAVR Durability for Women & Patients With Small Annuli
Love Story: Lipid Education for Women’s Heart Health
Clinical Conundrums in ARIA: Communicating ARIA Risk with Patients Considering Anti-Aβ Therapy
Impact of Barostim on Heart Failure Hospitalization
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?